These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 22439144)

  • 1. The combined effects of 3,4-methylenedioxymethamphetamine (MDMA) and selected substituted methcathinones on measures of neurotoxicity.
    Miner NB; O'Callaghan JP; Phillips TJ; Janowsky A
    Neurotoxicol Teratol; 2017 May; 61():74-81. PubMed ID: 28212938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity.
    Wood DM; Davies S; Puchnarewicz M; Button J; Archer R; Ovaska H; Ramsey J; Lee T; Holt DW; Dargan PI
    J Med Toxicol; 2010 Sep; 6(3):327-30. PubMed ID: 20358417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metaphedrone (3-Methylmethcathinone): Pharmacological, Clinical, and Toxicological Profile.
    Kelečević I; Vejnović AM; Javorac J; Gvozdenović N; Janjić N; Mijatović Jovin V
    Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541192
    [No Abstract]   [Full Text] [Related]  

  • 4. The Ability of Narcotic Detection Canines to Detect Illegal Synthetic Cathinones (Bath Salts).
    Shellman Francis V; Holness HK; Furton KG
    Front Vet Sci; 2019; 6():98. PubMed ID: 31024937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bath salts-induced psychosis: a case report.
    Mangewala V; Sarwar SR; Shah K; Singh T
    Innov Clin Neurosci; 2013 Feb; 10(2):10-1. PubMed ID: 23556135
    [No Abstract]   [Full Text] [Related]  

  • 6. Bath salts-induced delirium and brief psychotic episode in an otherwise healthy young man.
    Sharma TR; Iskandar JW; Ali R; Shah UR
    Prim Care Companion CNS Disord; 2012; 14(2):. PubMed ID: 22943019
    [No Abstract]   [Full Text] [Related]  

  • 7. The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter.
    Gannon BM; Baumann MH; Walther D; Jimenez-Morigosa C; Sulima A; Rice KC; Collins GT
    Neuropsychopharmacology; 2018 Nov; 43(12):2399-2407. PubMed ID: 30305739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bath salts: they are not what you think.
    Wieland DM; Halter MJ; Levine C
    J Psychosoc Nurs Ment Health Serv; 2012 Feb; 50(2):17-21. PubMed ID: 22439144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Illicit bath salts: not for bathing.
    Kyle PB; Iverson RB; Gajagowni RG; Spencer L
    J Miss State Med Assoc; 2011 Dec; 52(12):375-7. PubMed ID: 22329114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic cathinones (bath salts): legal status and patterns of abuse.
    Fass JA; Fass AD; Garcia AS
    Ann Pharmacother; 2012 Mar; 46(3):436-41. PubMed ID: 22388331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychoactive "bath salts" intoxication with methylenedioxypyrovalerone.
    Ross EA; Reisfield GM; Watson MC; Chronister CW; Goldberger BA
    Am J Med; 2012 Sep; 125(9):854-8. PubMed ID: 22682791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystallographic investigations of select cathinones: emerging illicit street drugs known as `bath salts'.
    Wood MR; Lalancette RA; Bernal I
    Acta Crystallogr C Struct Chem; 2015 Jan; 71(Pt 1):32-8. PubMed ID: 25567572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.
    Anneken JH; Angoa-Pérez M; Kuhn DM
    J Neurochem; 2015 Apr; 133(2):211-22. PubMed ID: 25626880
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.